Paper · 20226962

8p11 myeloproliferative syndrome: a review.

Jackson CC and 2 others. Hum Pathol, 2010. Cited by 190 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. 8p11 myeloproliferative syndrome: a review. Papers, record 20226962. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20226962

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: 8p11 myeloproliferative syndrome: a review.; PubMed
Journal: Hum Pathol; PubMed
Year: 2010; PubMed
Publication types: Journal Article, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/20226962/; PubMed
DOI: https://doi.org/10.1016/j.humpath.2009.11.003; PubMed
The journal: https://conductscience.org/library/journal-index/9421547; PubMed
Citations, by iCite: 190; iCite
Relative citation ratio, by iCite: 4.42; iCite
Revised in PubMed: 2010-03-15; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Jackson CC	Courtney C
2	Medeiros LJ	L Jeffrey
3	Miranda RN	Roberto N

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Chromosomes, Human, Pair 8	Major topic
Myeloproliferative Disorders	Major topic
Diagnosis, Differential
Humans
Receptor, Fibroblast Growth Factor, Type 1
Translocation, Genetic

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by104

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 190 citations.

PMID	Title	Journal	Year	In Papers	Source
42,840,391	TIF1/TRIM24::FGFR1-rearranged myeloid/lymphoid neoplasm with eosinophilia and tyrosine kinase gene fusion presenting as mixed-phenotype acute leukemia: a case report.	Leuk Res Rep	2026	https://conductscience.org/library/papers/42840391	PubMed
42,210,435	A gene signature derived from leukemia associated macrophages provides a compelling risk stratification for human AML patients.	Biomark Res	2026	https://conductscience.org/library/papers/42210435	PubMed
42,180,116	Case Report: Experience of a rare case of primary acute mast cell leukemia with FGFR1 gene rearrangement.	Front Oncol	2026	https://conductscience.org/library/papers/42180116	PubMed
41,266,899	A novel splicing variant of CNTRL::FGFR1 in myeloid/lymphoid neoplasm with eosinophilia and rearrangement of FGFR1.	J Hematop	2025	https://conductscience.org/library/papers/41266899	PubMed
41,180,818	Acute Lymphoblastic Leukemia Characterized by Rare BCR::FGFR1 Translocation: A Case Report With Literature Review.	Case Rep Hematol	2025	https://conductscience.org/library/papers/41180818	PubMed
41,090,761	Genomic Analysis Defines Increased Circulating, Leukemia-Induced Macrophages That Promote Immune Suppression in Mouse Models of FGFR1-Driven Leukemogenesis.	Cells	2025	https://conductscience.org/library/papers/41090761	PubMed
40,881,645	Identifying Drug Combination Strategies for ZMYM2: FGFR1 Fusion Positive Leukemia.	Precis Oncogenom	2025	https://conductscience.org/library/papers/40881645	PubMed
40,856,917	Granular acute lymphocytic leukemia : a case report and literature review.	Discov Oncol	2025	https://conductscience.org/library/papers/40856917	PubMed
40,590,913	TRAF3IP3::FGFR1: a novel FGFR1 fusion identified in an aggressive case of acute myeloid leukemia.	Ann Hematol	2025	https://conductscience.org/library/papers/40590913	PubMed
40,586,868	First report of B-lymphoblastic leukemia harboring LRRFIP1::FGFR1 fusion: expanding the clinical spectrum of myeloid/lymphoid neoplasms with tyrosine kinase gene fusions.	Ann Hematol	2025	https://conductscience.org/library/papers/40586868	PubMed

1 to 10 of 104

See all 104 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
FGFR1	2,260	PubTator's text mining	https://conductscience.org/library/genes/2260	NCBI Gene
ZMYM2	7,750	PubTator's text mining	https://conductscience.org/library/genes/7750	NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20226962

GET https://conductscience.org/api/papers/v1/20226962/cited_by?page=2

API reference For AI assistants